Module summary: 

This module introduces the concept of inclusive/universal design within the context of health and wellbeing in buildings and at the neighbourhood scale. It explores the perspectives of various people-related factors (e.g. age, health/wellbeing conditions, socioeconomic status and social exclusion, etc.), and within relevant building types and functions. Recent developments and debates on universal and inclusive design are explored. Guidelines and regulation, alongside design and operational principles, are addressed. 

Module aim and learning outcomes:

Upon successful completion of the module, the student should be able to:

Describe the relevance of unconscious bias and discrimination when designing environments for health and wellbeing
	Identify and interpret legislation and standards for accessibility and inclusive design, and their interpretation and application in practice
	Develop an understanding of a wide spectrum of user needs, including age, faith and a spectrum of impairments, including physical, sensory and cognitive conditions
	Determine the impact of inaccessible design and poor environmental design criteria
	Evaluate the social, cultural and economic advantages of inclusive design
	Convey clear and logical strategies for an inclusive design approach

Applied Biology|Biochemical Engineering|Bioengineering|Biomedical Engineering and Clinical Engineering|Biotechnology

Cell and gene therapy have emerged as two of the most significant therapeutic modalities of the 21st century. Both independently and in combination...

Cell and gene therapy have emerged as two of the most significant therapeutic modalities of the 21st century. Both independently and in combination (genetically modified cells), these technologies are starting to produce transformative therapies for patients across a broad range of medical fields including cancer immunotherapy and regenerative medicine. The need for scalable cost-effective manufacturing is a key requirement for the field. The content will include: Stem cells - Sourcing, characterisation and banking Stem cell expansion and differentiation The need for tightly controlled processes Characterisation with respect to stem cell bioprocessing Automation of stem cell bioprocessing Contract manufacture and stem cells Cell Therapies * Embryonic cells * Fetal and adult stem cells * Adult cells Tissue engineering Regulatory and economic challenges Ethics with respect to stem cell bioprocessing and commercialisation Case Studies: Stem cell-based therapies - scale up (allogeneic) and scale out (autologous). In particular the challenge of going from the lab-based discovery techniques into mass production to meet the demands of routine clinical practice

Upon completion of the course, a student should be able to:

Develop an understanding and working knowledge of manual cell handling, including those that are typically used at research scale and manufacturing scale.
	Develop an understanding and working knowledge of typical technology platforms and unit operations used in cell and gene therapy manufacturing pathways.
	Develop an understanding of how advanced therapies can be characterised and manufactured, including the use of automation technologies and bioanalytics.